Focal Cortical Dysplasia Type Ii

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2021-04-20
Clinical Trial Update: A Study Investigating the Anti-epileptic Efficacy of Afinitor (Everolimus) in Patients With Refractory Seizures Who Have Focal Cortical Dysplasia Type II (FCD II) [Phase 2]
Phase 2 trial investigating everolimus for refractory seizures in focal cortical dysplasia type II has completed.